Trials / Completed
CompletedNCT03903588
The Heidelberg Engineering SPECTRALIS Macular Precision and Agreement Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 86 (actual)
- Sponsor
- Heidelberg Engineering GmbH · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Accepted
Summary
This is a prospective clinical study that will be conducted at one clinical site located in the United States to assess two grids.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Optical Coherence Tomography | Imaging of the Retina |
Timeline
- Start date
- 2019-03-22
- Primary completion
- 2019-09-12
- Completion
- 2019-09-12
- First posted
- 2019-04-04
- Last updated
- 2020-10-22
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03903588. Inclusion in this directory is not an endorsement.